We have collected information about Depofoam Drug Delivery Technology for you. Follow the links to find out details on Depofoam Drug Delivery Technology.
http://www.pacira.com/products/depofoam
Our DepoFoam extended-release drug delivery technology can be applied to both small and large molecules, potentially improving patient care by providing a unique solution for medications that: Need to be administered by continuous infusion or frequent multiple injections
https://www.exparel.com/hcp/innovative-technology
Kohn FR, Malkmus SA, Brownson EA, Rossi SS, Yaksh TL. Fate of the predominant phospholipid component of DepoFoam drug delivery matrix after intrathecal administration of sustained-release encapsulated cytarabine in rats. Drug Deliv. 1998;5(2):143-151. Richard BM, Newton P, Ott LR, et al.
https://www.sciencedirect.com/science/article/pii/S0168365999001467
The versatility of DepoFoam drug delivery system as a vehicle for controlled delivery of protein and peptide drugs has been demonstrated. The rate of drug release in these formulations can be modulated to cover a relatively wide range of time courses, from one to two days up to several weeks.Author: Qiang Ye, John Asherman, Mark Stevenson, Elizabeth Brownson, Nandini V Katre
https://www.sciencedirect.com/science/article/pii/S0163782702000048
This article reviews the scientific basis of DepoFoam® technology, a lipid-based drug delivery system. A sustained release depot product (DepoCyt®) utilizing this technology has been clinically developed and recently approved for clinical use by regulatory agencies . DepoFoam formulations of drugs are intended for non-vascular, but parenteral ...Author: Sankaram Mantripragada
https://www.researchgate.net/publication/12673157_DepoFoamTM_technology_A_vehicle_for_controlled_delivery_of_protein_and_peptide_drugs
This challenge has been successfully met in the formulation of several peptide and protein drugs using the DepoFoam, multivesicular lipid-based drug delivery system. DepoFoam technology consists ...
https://www.exparel.com/sites/default/files/PP-EX-US-3647_EXPAREL_Fast_Facts_Update.pdf
EXPAREL uses DepoFoam®, an innovative drug delivery technology, to extend analgesia. 2 What is the clinical experience with EXPAREL? More than 4.5 million patients have received EXPAREL across a range of soft tissue (eg, abdominal, anorectal, breast, plastic surgery, reconstructive, and genitourinary), oral/maxillofacial,
https://link.springer.com/article/10.2165%2F00003088-200645120-00002
Sep 30, 2012 · Lamellar liposome technology has been used for several decades to produce sustained-release drug formulations for parenteral administration. Multivesicular liposomes are structurally distinct from lamellar liposomes and consist of an aggregation of hundreds of water-filled polyhedral compartments separated by bi-layered lipid septa. The unique architecture of multivesicular liposomes …Author: Martin S. Angst, David R. Drover
https://www.drugs.com/depodur.html
DepoDur is a novel single dose sustained-release injectable formulation of morphine providing 48 hours of post-surgical pain relief. About DepoDur. DepoDur is a single dose extended-release injectable formulation of morphine sulphate. DepoDur employs SkyePharma's proprietary DepoFoam technology and is supplied as a ready-to-use suspension.
https://www.ncbi.nlm.nih.gov/pubmed/17112293
Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology. Angst MS(1), Drover DR. Author information: (1)Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305-5117, USA. [email protected]: Martin S. Angst, David R. Drover
https://www.inc.com/profile/pacira-pharmaceuticals
Pacira Pharmaceuticals. Focuses on the development, commercialization, and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in ...
Searching for Depofoam Drug Delivery Technology?
You can just click the links above. The data is collected for you.
